Please login to the form below

Not currently logged in
Email:
Password:

ROAD Comms wins antimicrobial resistance account

Selected by GAMA Healthcare to create infection control campaign

ROAD CommunicationsROAD Communications has won a new account with infection control specialists GAMA Healthcare.

The London-based medical communications and PR agency has been tasked with creating a campaign in support of its range of advanced infection prevention technologies supplied to the NHS and other healthcare markets.

ROAD Communications will look to address the ever-increasing threat of antimicrobial resistance through the campaign, as hospitals try to counter both AMR and the risk that existing antibiotics are becoming less effective.

Paul Jarman, ROAD's managing director, said: “We're excited to be working with GAMA, a dynamic and fast-growing business.

“It is constantly innovating and challenging the possibilities of new technology in infection control.”

Watford, UK-based GAMA was behind the first universal disinfectant wipe - available in the UK under the Clinell brand, and its product portfolio also includes a range of safety scalpels.

Article by
Rebecca Clifford

20th September 2016

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics